1,252
Views
26
CrossRef citations to date
0
Altmetric
Report

Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention

, , , , , , , , ORCID Icon, , ORCID Icon, , , , ORCID Icon, , ORCID Icon & show all
Pages 356-361 | Received 18 Oct 2017, Accepted 09 Nov 2017, Published online: 19 Mar 2018

References

  • Chapman PB, Hauschild A, Robert C, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med. 2011;364:2507–2516. doi:10.1056/NEJMoa1103782. PMID:21639808
  • Flaherty LE, Othus M, Atkins MB, et al. Southwest Oncology Group S0008: a phase III trial of high-dose interferon Alfa-2b versus cisplatin, vinblastine, and dacarbazine, plus interleukin-2 and interferon in patients with high-risk melanoma–an intergroup study of cancer and leukemia Group B, Children's Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group. J Clin Oncol. 2014;32:3771–3778. doi:10.1200/JCO.2013.53.1590. PMID:25332243
  • Tang H, Wang Y, Chlewicki LK, et al. Facilitating T cell infiltration in tumor microenvironment overcomes resistance to PD-L1 blockade. Cancer Cell. 2016;29:285–296. doi:10.1016/j.ccell.2016.02.004. PMID:26977880
  • Brozyna AA, Jóźwicki W, Roszkowski K, et al. Melanin content in melanoma metastases affects the outcome of radiotherapy. Oncotarget. 2016;7:17844–17853. doi:10.18632/oncotarget.7528. PMID:26910282
  • Slominski AT, Carlson JA. Melanoma resistance: a bright future for academicians and a challenge for patient advocates. Mayo Clin Proc. 2014;89:429–433. doi:10.1016/j.mayocp.2014.02.009. PMID:24684870
  • Slominski AT, Brożyna AA, Zmijewski MA, et al. Vitamin D signaling and melanoma: role of vitamin D and its receptors in melanoma progression and management. Lab Invest. 2017;97:706–724. doi:10.1038/labinvest.2017.3. PMID:24684870
  • Hoffman RM. Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: a 40-year odyssey. Expert Opin Biol Ther. 2015;15:21–31. doi:10.1517/14712598.2015.963050. PMID:25439528
  • Kawaguchi K, Murakami T, Chmielowski B, et al. Vemurafenib-resistant BRAF-V600E mutated melanoma is regressed by MEK targeting drug trametinib, but not cobimetinib in a patient-derived orthotopic xenograft (PDOX) mouse model. Oncotarget. 2016;7:71737–71743. PMID:27690220
  • Kawaguchi K, Igarashi K, Murakami T, et al. Tumor-targeting Salmonella typhimurium A1-R combined with temozolomide regresses malignant melanoma with a BRAF-V600 mutation in a patient-derived orthotopic xenograft (PDOX) model. Oncotarget. 2016;7:85929–85936.
  • Kawaguchi K, Igarashi K, Murakami T, et al. Tumor-targeting Salmonella typhimurium A1-R sensitizes melanoma with a BRAF-V600E mutation to vemurafenib in a patient-derived orthotopic xenograft (PDOX) nude mouse model. J Cell Biochem. 2017;118:2314–2319. doi:10.1002/jcb.25886. PMID:PMID:28106277 PMID:27835903.
  • Kawaguchi K, Igarashi K, Li S, et al. Combination treatment with recombinant methioninase enables temozolomide to arrest a BRAF V600E melanoma growth in a patient-derived orthotopic xenograft. Oncotarget. 2017;8:85516–85525. PMID:29156737
  • Hoffman RM. Patient-derived orthotopic xenografts (PDOX) models of melanoma. Special Issue “Animal Models of Melanoma”, Slominski, A., Guest Editor. Intl J Mol Sci. 2017;18:1875. doi:10.3390/ijms18091875.
  • Hoffman RM, Erbe RW. High in vivo rates of methionine biosynthesis in transformed human and malignant rat cells auxotrophic for methionine. Proc Natl Acad Sci U S A. 1976;73:1523–1527. doi:10.1073/pnas.73.5.1523. PMID:179090
  • Stern PH, Mecham JO, Wallace CD, et al. Reduced free-methionine in methionine-dependent SV40-transformed human fibroblasts synthesizing apparently normal amounts of methionine. J Cell Physiol. 1983;117:9–14. doi:10.1002/jcp.1041170103. PMID:6311851
  • Stern PH, Wallace CD, Hoffman RM. Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines. J Cell Physiol. 1984;119:29–34. doi:10.1002/jcp.1041190106. PMID:6707100
  • Stern PH, Hoffman RM. Elevated overall rates of transmethylation in cell lines from diverse human tumors. In Vitro. 1984;20:663–670. doi:10.1007/BF02619617. PMID:6500606
  • Hoffman RM. Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis: a review and synthesis. Biochim Biophys Acta. 1984;738:49–87. PMID:6204687
  • Coalson DW, Mecham JO, Stern PH, et al. Reduced availability of endogenously synthesized methionine for S-adenosylmethionine formation in methionine dependent cancer cells. Proc Natl Acad Sci U S A. 1982;79:4248–4251. doi:10.1073/pnas.79.14.4248. PMID:6289297
  • Hoffman RM. Is DNA methylation the new guardian of genome? Mol Cytogenetics. 2017;10:11. doi:10.1186/s13039-017-0314-8.
  • Hoffman RM. The wayward methyl group and the cascade to cancer. Cell Cycle. 2017;16:825–829. doi:10.1080/15384101.2017.1304330. PMID:28318368
  • Tan Y, Sun X, Xu M, et al. Efficacy of recombinant methioninase in combination with cisplatin on human colon tumors in nude mice. Clin Cancer Res. 1999;5:2157–2163. PMID:10473100
  • Tan Y, Zavala J Sr, Xu M, et al. Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients. Anticancer Res. 1996;16:3937–3942. PMID:9042316
  • Tan Y, Zavala J Sr, Han Q, et al. Recombinant methioninase infusion reduces the biochemical endpoint of serum methionine with minimal toxicity in high-stage cancer patients. Anticancer Res. 1997;17:3857–3860. PMID:9427792
  • Kokkinakis DM, Hoffman RM, Frenkel EP, et al. Synergy between methionine stress and chemotherapy in the treatment of brain tumor xenografts in athymic mice. Cancer Res. 2001;61:4017–4023. PMID:11358820
  • Murakami T, Li S, Han Q, et al. Recombinant methioninase effectively targets a Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model. Oncotarget. 2017;8:35630–35638. PMID:28404944
  • Tan Y, Xu M, Tan X, et al. Overexpression and large-scale production of recombinant L-methionine-alpha- deamino-gamma-mercaptomethane-lyase for novel anticancer therapy. Protein Expr Purif. 1997;9:233–245. doi:10.1006/prep.1996.0700. PMID:9056489
  • Guo H, Lishko VK, Herrera H, et al. Therapeutic tumor-specific cell cycle block induced by methionine starvation in vivo. Cancer Res. 1993;53:5676–5679 PMID:8242623
  • Hoffman RM, Jacobsen SJ. Reversible growth arrest in simian virus 40-transformed human fibroblasts. Proc Natl Acad Sci U S A. 1980;77:7306–7310. doi:10.1073/pnas.77.12.7306. PMID:6261250
  • Kokkinakis DM, von Wronski MA, Vuong TH, et al. Regulation of O6-methylguanine-DNA methyltransferase by methionine in human tumour cells. Br J Cancer. 1997;75:779–788. doi:10.1038/bjc.1997.141. PMID:9062396
  • Kokkinakis DM, Schold SC Jr, Hori H, et al. Effect of long-term depletion of plasma methionine on the growth and survival of human brain tumor xenografts in athymic mice. Nutr Cancer. 1997;29:195–204. doi:10.1080/01635589709514624. PMID:9457739
  • Lishko VK, Lishko OV, Hoffman RM. The preparation of endotoxin-free L-methionine-alpha-deamino-gamma-mercaptomethane-lyase (L-methioninase) from Pseudomonas putida. Protein Expr Purif. 1993;4:529–533. doi:10.1006/prep.1993.1069. PMID:8286949
  • Tan Y, Zavala J Sr, Xu M, et al. Serum methionine depletion without side effects by methioninase in metastatic breast cancer patients. Anticancer Res. 1996;16:3937–3942. PMID:9042316
  • Hiroshima Y, Zhang Y, Murakami T, et al. Efficacy of tumor-targeting Salmonella typhimurium A1-R in combination with anti-angiogenesis therapy on a pancreatic cancer patient-derived orthotopic xenograph (PDOX) and cell line mouse models. Oncotarget. 2014;5:12346–12357. doi:10.18632/oncotarget.2641. PMID:25402324
  • Fu X, Guadagni F, Hoffman RM. A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens. Proc Natl Acad Sci U S A. 1992;89:5645–5649. doi:10.1073/pnas.89.12.5645. PMID:1608975
  • Hiroshima Y, Maawy A, Zhang Y, et al. Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19–9-conjugated fluorophore. PLoS One. 2014;9:e114310. doi:10.1371/journal.pone.0114310. PMID:25463150
  • Hiroshima Y, Maawy AA, Katz MH, et al. Selective efficacy of zoledronic acid on metastasis in a patient-derived orthotopic xenograph (PDOX) nude-mouse model of human pancreatic cancer. J Surg Oncol. 2015;111:311–315. doi:10.1002/jso.23816. PMID:25394368
  • Fu X, Le P, Hoffma RM. A metastatic-orthotopic transplant nude-mouse model of human patient breast cancer. Anticancer Res. 1993;13:901–904. PMID:8352558
  • Fu X, Hoffman RM. Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically-intact patient specimens. Anticancer Res. 1993;13:283–286. PMID:8517640
  • Wang X, Fu X, Hoffman RM. A new patient-like metastatic model of human lung cancer constructed orthotopically with intact tissue via thoracotomy in immunodeficient mice. Int J Cancer. 1992;51:992–995. doi:10.1002/ijc.2910510626. PMID:1639545
  • Hiroshima Y, Zhang Y, Zhang N, et al. Establishment of a patient-derived orthotopic xenograph (PDOX) model of HER-2-positive cervical cancer expressing the clinical metastatic pattern. PLoS One. 2015;10:e0117417. doi:10.1371/journal.pone.0117417. PMID:25689852
  • Fu X, Besterman JM, Monosov A, et al. Models of human metastatic colon cancer in nude mice orthotopically constructed by using histologically intact patient specimens. Proc Natl Acad Sci U S A. 1991;88:9345–9349. doi:10.1073/pnas.88.20.9345. PMID:1924398
  • Metildi CA, Kaushal S, Luiken GA, et al. Fluorescently-labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model. J Surg Oncol. 2014;109:451–458. doi:10.1002/jso.23507. PMID:24249594
  • Hiroshima Y, Maawy A, Metildi CA, et al. Successful fluorescence-guided surgery on human colon cancer patient-derived orthotopic xenograft mouse models using a fluorophore-conjugated anti-CEA antibody and a portable imaging system. J Laparoendosc Adv Surg Tech A. 2014;24:241–247. doi:10.1089/lap.2013.0418. PMID:24494971
  • Furukawa T, Kubota T, Watanabe M, et al. Orthotopic transplantation of histologically intact clinical specimens of stomach cancer to nude mice: correlation of metastatic sites in mouse and individual patient donors. Int J Cancer. 1993;53:608–612. doi:10.1002/ijc.2910530414. PMID:8436434
  • Murakami T, DeLong J, Eilber FC, et al. Tumor-targeting Salmonella typhimurium A1-R in combination with doxorubicin eradicate soft tissue sarcoma in a patient-derived orthotopic xenograft PDOX model. Oncotarget. 2016;7:12783–12790. doi:10.18632/oncotarget.7226. PMID:26859573
  • Hiroshima Y, Zhao M, Zhang Y, et al. Tumor-targeting Salmonella typhimurium A1-R arrests a chemo-resistant patient soft-tissue sarcoma in nude mice. PLoS One. 2015;10:e0134324. doi:10.1371/journal.pone.0134324. PMID:26237416
  • Kiyuna T, Murakami T, Tome Y, et al. High efficacy of tumor-targeting Salmonella typhimurium A1-R on a doxorubicin- and dactolisib-resistant follicular dendritic-cell sarcoma in a patient-derived orthotopic xenograft PDOX nude mouse model. Oncotarget. 2016;7:33046–33054. doi:10.18632/oncotarget.8848. PMID:27105519
  • Murakami T, Singh AS, Kiyuna T, et al. Effective molecular targeting of CDK4/6 and IGF-1R in a rare FUS-ERG fusion CDKN2A-deletion doxorubicin-resistant Ewing's sarcoma in a patient-derived orthotopic xenograft (PDOX) nude-mouse model. Oncotarget. 2016;7:47556–47564. doi:10.18632/oncotarget.9879. PMID:27286459
  • Hiroshima Y, Zhang Y, Zhang N, et al. Patient-derived orthotopic xenograft (PDOX) nude mouse model of soft-tissue sarcoma more closely mimics the patient behavior in contrast to the subcutaneous ectopic model. Anticancer Res. 2015;35:697–701. PMID:25667448
  • Yamamoto M, Zhao M, Hiroshima Y, et al. Efficacy of tumor-targeting Salmonella typhimurium A1-R on a melanoma patient-derived orthotopic xenograft (PDOX) nude-mouse model. PLoS One. 2016;11:e0160882. doi:10.1371/journal.pone.0160882. PMID:27500926
  • Blagosklonny MV. Matching targets for selective cancer therapy. Drug Discov Today. 2003;8:1104–1107. doi:10.1016/S1359-6446(03)02806-X. PMID:14678733
  • Blagosklonny MV. Teratogens as anti-cancer drugs. Cell Cycle. 2005;4:1518–1521. doi:10.4161/cc.4.11.2208. PMID:16258270
  • Blagosklonny MV. Treatment with inhibitors of caspases, that are substrates of drug transporters, selectively permits chemotherapy-induced apoptosis in multidrug-resistant cells but protects normal cells. Leukemia. 2001;15:936–941. doi:10.1038/sj.leu.2402127. PMID:11417480
  • Blagosklonny MV. Target for cancer therapy: proliferating cells or stem cells. Leukemia. 2006;20:385–391. doi:10.1038/sj.leu.2404075. PMID:16357832
  • Apontes P, Leontieva OV, Demidenko ZN, et al. Exploring long-term protection of normal human fibroblasts and epithelial cells from chemotherapy in cell culture. Oncotarget. 2011;2:222–233. doi:10.18632/oncotarget.248. PMID:21447859
  • Blagosklonny MV. Tissue-selective therapy of cancer. Br J Cancer. 2003;89:1147–1151. doi:10.1038/sj.bjc.6601256. PMID:14520435
  • Jones BN, Gilligan JP. o-Phthaldialdehyde precolumn derivatization and reversed-phase high-performance liquid chromatography of polypeptide hydrolysates and physiological fluids. J Chromatogr. 1983;266:471–482. doi:10.1016/S0021-9673(01)90918-5. PMID:6630358

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.